Dietary Supplements: Primer & FDA Oversight

FDA has taken some steps to identify and act upon safety concerns related to dietary supplements; however, several factors limit the agency’s ability to detect concerns and remove products from the market. For example, FDA has limited information on the number and location of dietary supplement firms, the types of products currently available in the marketplace, and information about moderate and mild adverse events reported to industry. Additionally, FDA dedicates relatively few resources to oversight activities, such as providing guidance to industry regarding notification requirements for products containing new dietary ingredients. This book highlights the limited steps taken by the FDA to educate consumers about dietary supplements and their risks. This book consists of public documents which have been located, gathered, combined, reformatted, and enhanced with a subject index, selectively edited and bound to provide easy access.